H1N1 influenza vaccine (alpha-mannatide adjuvant) (Shanxi Maike Aote Technology/GlaxoSmithKline)

N/A

Report date: 2026/01/26 17:59:03

Base Information

Drug NameH1N1 influenza vaccine (alpha-mannatide adjuvant) (Shanxi Maike Aote Technology/GlaxoSmithKline)
Drug Alias NameH1N1 influenza vaccine (alpha-mannatide adjuvant) (Shanxi Maike Aote Technology/Zhejiang Tianyuan Bio-Pharmaceutical)
ClassificationVaccines
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShaanxi Micot Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShaanxi Micot Pharmaceutical Technology Co LtdGlaxosmithkline PlcZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A